Track the ILLUMINA INC share price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €28.4bn. The latest transaction was filed on 30 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: FLATLEY JAY T. All data is accessible without an account.
48
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
17 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate ILLUMINA INC Buy (bullish), based on 19 analysts. Average price target: US$198.89.
23Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,076 of 28,932 companies
59.1
score / 100
Value
39
Quality
79
FCF yld2.7%
Earn yld2.5%
EV/EBITDA25.1x
ROE32%
Gross mgn66%
Net mgn20%
Debt/EBITDA1.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Illumina Inc is a company specializing in genetic sequencing and molecular biology technologies. It provides solutions for genomics research and medical diagnostics.